Clinical Trial Update: Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II [Phase 2, Phase 3]

View source ↗

Summary

The update reports results from a Phase 2/Phase 3 study of salsalate for Type 2 Diabetes Mellitus. The trial is completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Disalcid (salsalate)

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-11-25